A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

NCT01754818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Bendavia 10mg
DRUG: Bendavia 50mg
DRUG: Bendavia 100mg
DRUG: Placebo

Sponsor

Stealth BioTherapeutics Inc.